United States· US:50090-7091_90dcd7f5-e0f8-454d-89b5-2eedeff32e54
cephalexin
A cefalexin product containing cephalexin, registered in United States by A-S Medication Solutions. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cefalexin is registered in 14 of 19 countries.
Countries holding a registration under ATC J01DB01 (cefalexin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Cefalexin · ATC J01DB01
14 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefalexin costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $0.72 in United States to $1.28 in Spain — a ×1.8 gap.
- United States: $0.72 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Cefalexin · price per daily dose (2 g)
USD · FX 28 Sept 2026
- ES Spain$1.28
- US United States$0.72 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CEPHALEXIN
- Manufacturer
- A-S Medication Solutions
- Country
- United States (US)
- ATC code
- J01DB01
- ATC class
- Cefalexin
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1150090-7091-0
- ndc115009070910200 mL in 1 BOTTLE (50090-7091-0)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
223 interactions on record for cefalexin.
Graded by severity as the source publishes them — 13 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefalexin · interactions on record
223 records
- 13 moderate
- 210 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- BalsalazideA07EC04moderate
- MetforminA10BA02moderate
- DicoumarolB01AA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefalexin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCefalexin 125mg/5ml oral suspensionKent Pharma (UK) Ltd
- FinlandCefabactin vetLe Vet. Beheer B.V.
- CanadaAPO-CEPHALEXAPOTEX INC
- IrelandKeflex 125 mg/5 ml Powder for Oral SuspensionFlynn Pharma Limited
- GermanyCefalexin Reiwa HealthcareReiwa Healthcare S.L
- SpainCEFALEXINA NORMON 500 mg CAPSULAS DURASLaboratorios Normon S.A.
- ItalyCEPOREX*8 cpr rivestite 1 gTEOFARMA Srl
- NorwayKeflexEurocept International B.V
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Cephalobene, Keflex
- Belgium · Keforal
- Bulgaria · Оспексин
- Cyprus · Felexin, Keflex
- Germany · Cefalexin Reiwa Healthcare, Cephalex-Ct
- Denmark · Keflex
- Spain · Cefalexina Normon, Cefalexina Reiwa Healthcare
- Finland · Kefalex, Kefexin
- France · Keforal, Kéforal
- United Kingdom (Northern Ireland) · Cefalexin, Cefalexin Ascend Laboratories (Uk)
- Croatia · Cefaleksin Belupo, Cefalexin Alkaloid
- Hungary · Cefalexin Reiwa Healthcare, Pyassan 250 Mg Kemény Kapszula
- Ireland · Keflex
- Italy · Ceporex, Keforal
- Luxembourg · Keforal
- Malta · Keflex
- Netherlands · Keforal
- Norway · Keflex
- Poland · Cefaleksyna Tzf
- Romania · Cefalexină Arena, Cefalexina Atb
- Slovakia · Ospexin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9fd4dcee-bcce-4448-b75f-41acdf61b886 GET /v1/drugs/9fd4dcee-bcce-4448-b75f-41acdf61b886?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "250",
"substance": "CEPHALEXIN",
"productndc": "50090-7091",
"dosage_form": "FOR SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/5mL",
"application_number": "ANDA065234",
"marketing_category": "ANDA"
}See everything about cefalexin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.